ImageneBio IMA
NASDAQ IMA
$5.67 +0.06 (+1.08%)
As of: Aug 21, 2026 · 11:28 AM EDT

ImageneBio (IMA) FCF Margin Growth (5y) (2025)

ImageneBio (IMA) FCF Margin Growth (5y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.20 Bn 131.35 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.09 Bn 78.10 Bn 3.93 Bn
3 Argenx Se 65.25 Bn 60.07 Bn 1.37 Bn
4 Moderna 59.04 Bn 53.90 Bn 52.00 Mn
5 BeOne Medicines 42.04 Bn 36.94 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn
7 BioNTech SE 28.04 Bn 9.65 Bn 668.28 Mn
8 Insmed 27.50 Bn 26.33 Bn 358.27 Mn
9 Royalty Pharma 27.34 Bn 26.50 Bn -
10 ImageneBio 48.35 Mn -87.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -59,414.00